The BENeFiTS Trial in Beta Thalassemia Intermedia
Clinical trial NCT04432623 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT04432623
- Sponsor
- Phoenicia BioScience
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-05
- Primary completion
- 2026-02-28
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.